0001225208-15-020459.txt : 20151110
0001225208-15-020459.hdr.sgml : 20151110
20151106105238
ACCESSION NUMBER: 0001225208-15-020459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151105
FILED AS OF DATE: 20151106
DATE AS OF CHANGE: 20151106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 GORDON DR
STREET 2: P O BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 101 GORDON DRIVE
STREET 2: PO BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDERSON MICHAEL A
CENTRAL INDEX KEY: 0001213304
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 151202983
4
1
doc4.xml
X0306
4
2015-11-05
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001213304
ANDERSON MICHAEL A
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
1
Vice President & Treasurer
Common Stock
2015-11-05
4
M
0
10000.0000
22.4850
A
74497.0200
D
Common Stock
2015-11-05
4
S
0
10000.0000
61.9817
D
64497.0200
D
Common Stock
911.8938
I
By Savings Plan
Common Stock
7333.4100
I
Non-Qualified Deferred Compensation Plan
Stock Option (Right to Buy)
22.4850
2015-11-05
4
M
0
10000.0000
22.4800
D
2008-02-27
2018-02-27
Common Stock
10000.0000
1414.0000
D
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $61.97 to $62.02, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
Joanne K. Boyle as Agent for Michael A. Anderson
2015-11-06